ReviewBiodesign research2025
Advances in the microbial biosynthesis of ʟ-tryptophan and its derivatives.
Review in Biodesign research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Engineering a heme-dependent tryptophan hydroxylase pathway inSynthetic and systems biotechnology · 2026Article
- Metabolic engineering of Streptomyces albulus for de novo serotonin production.Microbial cell factories · 2026Article
- Engineering yeast for sustainable bioproduction of tryptophan-derived aromatic compounds.FEMS yeast research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
l-Tryptophan, an essential aromatic amino acid, is widely used in the pharmaceutical and food industries owing to its distinctive indole ring structure, which is unique among proteinogenic amino acids. Moreover, structurally modified derivatives of l-tryptophan have drawn considerable attention from researchers due to their improved functional properties. Recently, microbial synthesis has emerged as an environmentally sustainable approach for producing l-tryptophan and its derivatives. While significant progress has been made in optimizing biosynthetic pathways, several key bottlenecks remain. This review surveys recent optimizations that increase microbial l-tryptophan titers and the resulting engineered strains for their high-value derivatives. Moreover, transformative opportunities for advancing l-tryptophan derivatives production, offered by the rapid evolution of synthetic biology, are discussed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.